Home » Stocks » HCYT


Stock Price: $0.0400 USD -0.0060 (-13.04%)
Updated Jan 19, 2021 3:46 PM EST - Market closed
Market Cap 6.66M
Revenue (ttm) 3.53M
Net Income (ttm) -26.33M
Shares Out 116.97M
EPS (ttm) -0.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 19
Last Price $0.0400
Previous Close $0.0460
Change ($) -0.0060
Change (%) -13.04%
Day's Open 0.0400
Day's Range 0.0311 - 0.0460
Day's Volume 94,977
52-Week Range 0.006 - 0.196


There are no news available yet.

About HCYT

H-CYTE, a medical biosciences company, develops and implements various treatment options in regenerative medicine to treat chronic lung diseases. It engages in the development of L-CYTE-01 for the treatment of chronic obstructive pulmonary diseases. The company is headquartered in Tampa, Florida.

Medical Devices
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

In 2019, H-CYTE, Inc.'s revenue was $8.35 million, an increase of 5.88% compared to the previous year's $7.88 million. Losses were -$29.81 million, 578.4% more than in 2018.

Financial Statements